Outcomes among venous thromboembolism patients who were admitted into the emergency department and treated with apixaban or warfarin in the U.S. (VTE CER in Premier ED) First published 03/06/2019 Last updated 27/04/2020 EU PAS number:EUPAS29963 Study Finalised